(Q35953246)

11 August 2017

1 reference

title

Ifosfamide-induced neurotoxicity: a case report and review of the literature (English)

1 reference

11 August 2017

1 reference

1 reference

L. J. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1554927

8 October 2022

V. E. Eaton

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1554927

8 October 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

full work available at URL

11 August 2017

http://www.theannals.com/cgi/content/abstract/26/2/183

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1554927

Annals of Pharmacotherapy

8 October 2022

published in

1 reference

11 August 2017

26

1 reference

11 August 2017

183-187

1 reference

11 August 2017

2

1 reference

Central nervous side effects following ifosfamide monotherapy of advanced renal carcinoma

11 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Encephalopathy associated with ifosphamide/mesna therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide encephalopathy: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Prediction of ifosfamide/mesna associated encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Avoiding ifosfamide/mesna encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Encephalopathy with rapid infusion ifosfamide/mesna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide by continuous infusion to prevent encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide neurotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

A phase II study of ifosfamide in children with recurrent solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide/mesa and encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Irreversible encephalopathy with ifosfamide/mesna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

Fatal Encephalopathy with Ifosfamide/Mesna

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809202600207

10.1177/106002809202600207

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference